发明名称 |
THERAPEUTIC DRUG FOR DIABETES |
摘要 |
<p>A medicament for preventive and/or therapeutic treatment of diabetes or complications of diabetes which comprises as an active ingredient a substance selected from the group consisting of a compound represented by the following general formula (I) and a pharmacologically acceptable salt thereof, and a hydrate thereof and a solvate thereof: <CHEM> wherein X represents a connecting group whose number of atoms in the main chain is 2 to 5 (said connecting group may be substituted), A represents hydrogen atom or acetyl group, E represents an aryl group which may be substituted or a hetero aryl group which may be substituted, ring Z represents an arene which may have one or more substituents in addition to the group represented by formula -O-A wherein A has the same meaning as that defined above and the group represented by formula -X-E wherein each of X and E has the same meaning as that defined above, or a heteroarene which may have one or more substituents in addition to the group represented by formula -O-A wherein A has the same meaning as that defined above and the group represented by formula -X-E wherein each of X and E has the same meaning as that defined above.</p> |
申请公布号 |
EP1510207(A1) |
申请公布日期 |
2005.03.02 |
申请号 |
EP20030730841 |
申请日期 |
2003.06.05 |
申请人 |
INSTITUTE OF MEDICINAL MOLECULAR DESIGN, INC. |
发明人 |
MUTO, SUSUMU;ITAI, A. |
分类号 |
A61K31/055;A61K31/121;A61K31/15;A61K31/166;A61K31/167;A61K31/17;A61K31/18;A61K31/185;A61K31/194;A61K31/216;A61K31/222;A61K31/235;A61K31/275;A61K31/341;A61K31/357;A61K31/36;A61K31/381;A61K31/40;A61K31/403;A61K31/4035;A61K31/44;A61K31/4402;(IPC1-7):A61K31/055;A61K31/404 |
主分类号 |
A61K31/055 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|